Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Licensing revenue	$ 125,000	$ 125,000	$ 250,000	$ 250,000
Operating expenses:
Research and development	3,165,473	2,022,576	6,058,641	5,225,753
General and administrative	2,305,208	1,950,720	4,739,065	3,639,449
Acquisition costs	1,067,267		1,067,267
Total operating expenses	6,537,948	3,973,296	11,864,973	8,865,202
Loss from operations	(6,412,948)	(3,848,296)	(11,614,973)	(8,615,202)
Other (expense) income:
(Loss) gain from change in valuation of common stock warrant liability	(18,613)	4,380,120	(15,587)	8,660,417
Investment income, net	23,734	67,132	30,753	83,695
Interest expense	(263,115)	(176,211)	(493,828)	(357,139)
Other expense	(2,488)	(1,861)	(2,488)	(1,861)
Total other (expense) income, net	(260,482)	4,269,180	(481,150)	8,385,112
Net income (loss)	(6,673,430)	420,884	(12,096,123)	(230,090)
Non-cash deemed dividend from beneficial conversion feature on convertible preferred stock				(4,601,410)
Net (loss) income attributable to common shareholders	$ (6,673,430)	$ 420,884	$ (12,096,123)	$ (4,831,500)
Net income (loss) attributable to common shareholders per common share
Basic and diluted (in Dollars per share)	$ (0.38)	$ 0.03	$ (0.71)	$ (0.45)
Weighted average shares outstanding
Basic (in Shares)	17,526,531	12,087,004	16,931,914	10,807,003
Diluted (in Shares)	17,526,531	13,617,726	16,931,914	10,807,003